These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 46060)

  • 1. Editorial: Levamisole.
    Lancet; 1975 Jan; 1(7899):151-2. PubMed ID: 46060
    [No Abstract]   [Full Text] [Related]  

  • 2. [Levamisole -- a drug modifying immunologic phenomena].
    Bogdanikowa B
    Postepy Hig Med Dosw; 1979; 33(2):125-46. PubMed ID: 384382
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological and immunotherapeutic properties of levamisole (a review of the literature)].
    Sakharchuk II; Skakal'skaia LM
    Vrach Delo; 1982 Aug; (8):4-8. PubMed ID: 6983185
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of Bacillus Calmette-Guérin and levamisole on immune responses in young adult and age-immunodepressed mice.
    Bruley-Rosset M; Florentin I; Kiger N; Davigny M; Mathé G
    Cancer Treat Rep; 1978 Nov; 62(11):1641-50. PubMed ID: 728893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor activity and the effect on immunogenesis of combinations of rubomycin and carminomycin with levamisole].
    Vatin AE; Filatov PP
    Antibiotiki; 1982 Apr; 27(4):284-7. PubMed ID: 6896414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levamisole: a synthetic immunopotentiator under evaluation.
    Hadden JW
    Clin Bull; 1975; 5(1):32-3. PubMed ID: 819182
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Levamisole and the immune response.
    N Engl J Med; 1973 Nov; 289(21):1148-9. PubMed ID: 4585358
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of cutaneous leishmaniasis in the guinea-pig by cyclophosphamide.
    Belehu A; Poulter LW; Turk JL
    Clin Exp Immunol; 1976 Apr; 24(1):125-32. PubMed ID: 949870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The immunomodulating effect of levamisole in animal experiments].
    Sikorska H
    Reumatologia; 1979; 17(3):339-47. PubMed ID: 390660
    [No Abstract]   [Full Text] [Related]  

  • 10. [Various aspects of the mechanism of action of levamisole].
    Chumakova MM
    Ter Arkh; 1978; 50(9):146-53. PubMed ID: 360467
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of cancer with immunomodulators.
    Oettgen HF; Pinsky CM; Delmonte L
    Med Clin North Am; 1976 May; 60(3):511-37. PubMed ID: 1271891
    [No Abstract]   [Full Text] [Related]  

  • 12. [Targets and mechanisms of levamisole-induced immunostimulation (author's transl)].
    Renoux G; Renoux M
    Nouv Presse Med; 1978 Jan; 7(3):197-201. PubMed ID: 307228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Levamisole, a chemically defined substance with immunostimulating potential--a review].
    Staber GF
    Fortschr Med; 1976 May; 94(14):793-800. PubMed ID: 5347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the immunostimulatory activity of levamisole.
    Mantovani A; Spreafico F
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:302. PubMed ID: 4859247
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiments in the rat showing aspects of the immunomodulating activity of levamisole. 1) Effect of levamisole on antibody production and on the phenomenon of specific immune cytoadherence].
    Gorini P; Corridori S; Scevola D; Marone P; Vender A
    Riv Emoter Immunoematol; 1978; 25(5-6):223-33. PubMed ID: 555029
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of cyclophosphamide on the delayed hypersensitivity in the mouse after intraperitoneal immunization.
    Kerckhaert JA
    Ann Immunol (Paris); 1974 Jun; 125 C(4):559-68. PubMed ID: 4548829
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunomodulatory activity of biopolymeric fraction BOS 2000 from Boswellia serrata.
    Khajuria A; Gupta A; Suden P; Singh S; Malik F; Singh J; Gupta BD; Suri KA; Srinivas VK; Ella K; Qazi GN
    Phytother Res; 2008 Mar; 22(3):340-8. PubMed ID: 18167047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levamisole in the modulation of the immune response: the current experimental and clinical state.
    Symoens J; Rosenthal M
    J Reticuloendothel Soc; 1977 Mar; 21(3):175-221. PubMed ID: 142150
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of rubomycin C on immunological reactivity of organism].
    Artemova LK; Shapovalova SP
    Antibiotiki; 1970 Jan; 15(1):63-7. PubMed ID: 4909952
    [No Abstract]   [Full Text] [Related]  

  • 20. Levamisole, an anti-anergic chemotherapeutic agent: experimental and clinical findings.
    Hobeke J
    Adv Exp Med Biol; 1976; 73 PT-A():422-4. PubMed ID: 998417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.